Common Contracts

11 similar Underwriting Agreement contracts by RealD Inc., Seattle Genetics Inc /Wa, Affinia Group Holdings Inc., others

ROSETTA RESOURCES INC. 7,000,000 Shares of Common Stock Underwriting Agreement
Underwriting Agreement • April 23rd, 2013 • Rosetta Resources Inc. • Crude petroleum & natural gas • New York

Rosetta Resources Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 7,000,000 shares of Common Stock, par value $0.001 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 1,050,000 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

Insulet Corporation 4,100,000 Shares Common Stock ($0.001 par value) Underwriting Agreement
Underwriting Agreement • January 4th, 2013 • Insulet Corp • Surgical & medical instruments & apparatus • New York
FENDER MUSICAL INSTRUMENTS CORPORATION Shares of Common Stock Underwriting Agreement
Underwriting Agreement • June 25th, 2012 • Fender Musical Instruments Corp • New York

Fender Musical Instruments Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of shares of Common Stock, par value $ 0.01 per share, of the Company, and certain stockholders of the Company named in Schedule 2 hereto (the “Selling Stockholders”) propose to sell to the several Underwriters an aggregate of shares of Common Stock of the Company (collectively, the “Underwritten Shares”). In addition, the Selling Stockholders propose to sell, at the option of the Underwriters, up to an additional shares of Common Stock of the Company (collectively, the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

10,000,000 Shares SEATTLE GENETICS, INC. Common Stock ($0.001 par value per Share) UNDERWRITING AGREEMENT February 2, 2011
Underwriting Agreement • February 2nd, 2011 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • New York

Seattle Genetics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 10,000,000 shares of common stock, par value $0.001 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 1,500,000 shares of common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are herein referred to as the “Stock”.

REALD INC. [·] Shares of Common Stock Underwriting Agreement
Underwriting Agreement • November 22nd, 2010 • RealD Inc. • Radio & tv broadcasting & communications equipment • New York

Stockholders of RealD Inc., a Delaware corporation (the “Company”), named in Schedule 2 hereto (the “Selling Stockholders”) propose to sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [•] shares of common stock, par value $0.0001 per share, of the Company (collectively, the “Underwritten Shares”). In addition, the Selling Stockholders propose to sell, at the option of the Underwriters, up to an additional [•] shares of common stock of the Company (collectively, the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

Affinia Group Holdings Inc. [—] Shares of Common Stock Underwriting Agreement
Underwriting Agreement • August 12th, 2010 • Affinia Group Holdings Inc. • Motor vehicle parts & accessories • New York

Affinia Group Holdings Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [—] shares of common stock, par value $0.01 per share (the “Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional [—] shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are herein referred to as the “Stock”.

REALD INC. [·] Shares of Common Stock Underwriting Agreement
Underwriting Agreement • May 26th, 2010 • RealD Inc. • Radio & tv broadcasting & communications equipment • New York

RealD Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [·] shares of common stock, par value $0.0001 per share, of the Company, and certain stockholders of the Company named in Schedule 2 hereto (the “Selling Stockholders”) propose to sell to the several Underwriters an aggregate of [·] shares of common stock of the Company (collectively, the “Underwritten Shares”). In addition, the Company proposes to issue and sell, at the option of the Underwriters, up to an additional [·] shares of common stock of the Company, and the Selling Stockholders propose to sell, at the option of the Underwriters, up to an additional [·] shares of common stock of the Company (collectively, the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock o

CENTRAL EUROPEAN DISTRIBUTION CORPORATION 10,250,000 Shares of Common Stock Underwriting Agreement
Underwriting Agreement • November 24th, 2009 • Central European Distribution Corp • Wholesale-beer, wine & distilled alcoholic beverages • New York

Central European Distribution Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), an aggregate of 10,250,000 shares of common stock, par value $0.01 per share (the “Common Stock”), of the Company (the “Underwritten Shares”). In addition, the Company proposes to issue and sell to the Underwriters, at the option of the Underwriters, up to an additional 1,025,000 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to collectively as the “Shares.” Jefferies & Company, Inc. and UniCredit CAIB Securities UK Ltd. have agreed to act as representatives of the several Underwriters (in such capacity, the “Representatives”) in connection with the offering and sale of the Shares.

SEATTLE GENETICS, INC. 11,000,000 Shares of Common Stock Underwriting Agreement
Underwriting Agreement • August 12th, 2009 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • New York

Seattle Genetics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 11,000,000 shares of common stock, par value $0.001 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 1,650,000 shares of common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are herein referred to as the “Stock”.

GENOMIC HEALTH, INC. 3,000,000 Shares of Common Stock, par value $0.0001 per share Underwriting Agreement
Underwriting Agreement • May 22nd, 2007 • Genomic Health Inc • Services-medical laboratories • New York

Genomic Health, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 3,000,000 shares of Common Stock, par value $0.0001 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 450,000 shares of common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are herein referred to as the “Stock”.

COINSTAR, INC. [ ] Shares of Common Stock, $0.001 par value Form of Underwriting Agreement
Underwriting Agreement • December 7th, 2004 • Coinstar Inc • Services-personal services • New York

Coinstar, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [ ] shares of its Common Stock, par value $0.001 per share (the “Underwritten Shares”) and, for the sole purpose of covering over-allotments in connection with the sale of the Underwritten Shares, up to an additional [ ] shares of its Common Stock (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock, par value $0.001 per share of the Company to be outstanding after giving effect to the sale of the Shares are herein referred to as the “Common Stock”. The Common Stock, including the Shares, will have attached thereto rights (the “Rights”) to purchase Series A Junior Participating Preferred Stock, par value $0.001 per share. The Rights are to be issued pursuant to a